TM6SF1 activators belong to a class of chemical compounds that interact with the transmembrane 6 superfamily member 1 (TM6SF1) protein. This protein is embedded in the cellular membrane and plays a role in various cellular processes. The activators are designed to modulate the function of this protein through direct interaction, which can lead to a change in its activity. The chemical structure of these activators is diverse, yet they share the commonality of being able to bind or influence TM6SF1. The exact mechanisms through which TM6SF1 activators exert their effects can vary, but they generally involve alterations in the conformation of the protein, which may affect its interaction with other cellular components or its ability to perform its function within the cellular membrane.
The discovery and development of TM6SF1 activators is a complex process that involves understanding the protein's structure and function at a molecular level. Researchers use a variety of techniques to identify molecules that could potentially act as activators. Once potential activators are identified, they undergo a series of tests to determine their efficacy in modulating the protein's activity. This can include biochemical assays, which measure the activity of TM6SF1 in the presence of the compound, as well as studies to determine the binding affinity and specificity of the activator to TM6SF1. The chemical properties of TM6SF1 activators are finely tuned to ensure that they can effectively interact with the protein within the complex environment of the cell membrane, which is composed of a lipid bilayer and various other proteins and molecules.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, leading to an increase in cyclic AMP (cAMP) levels. Elevated cAMP can activate PKA, which may phosphorylate and thereby enhance the activity of TM6SF1 by facilitating its proper localization within membrane domains. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, enzymes that degrade cAMP. By preventing cAMP breakdown, IBMX indirectly sustains PKA activation which can enhance TM6SF1 function. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC) which could phosphorylate TM6SF1 or associated proteins, leading to enhanced TM6SF1-mediated signaling. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is an ionophore that increases intracellular calcium levels, potentially activating calcium-dependent kinases that enhance TM6SF1 activity through phosphorylation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore which elevates intracellular Ca2+ concentration, leading to the activation of calcium-dependent signaling pathways that could enhance TM6SF1 activity. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid is a potent inhibitor of protein phosphatases 1 and 2A, leading to increased phosphorylation levels of proteins, which may include TM6SF1, thus indirectly enhancing its activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known for its ability to inhibit certain types of kinases. This inhibition can shift the balance of cellular signaling pathways, potentially favoring those that activate TM6SF1. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can lead to the activation of alternative pathways or compensatory signaling that may upregulate TM6SF1 activity in response to reduced PI3K signaling. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a MEK inhibitor that may lead to the activation of compensatory pathways which can enhance TM6SF1 activity, as the cell seeks to maintain homeostasis in the face of inhibited MEK. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate is a bioactive lipid that can activate sphingosine-1-phosphate receptors and downstream signaling pathways potentially leading to the activation of TM6SF1. | ||||||